Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
Conditions: Cardiovascular Diseases; Carotid Artery Diseases; Intracranial Arteriosclerosis; Cerebrovascular Disorders; Heart Diseases; Vascular Diseases; Atherosclerosis
Interventions: Drug: Vitamin E; Drug: Vitamin C
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Terminated - verified October 2006
Compromised Skin Barrier Function Plays A Role In Psoriasis Development
New research on genetic basis of psoriasis may prove important for early diagnosis and prediction of an individual's risk for this common chronic skin disease.
Pinning Down A Cause Of Disease In A Model Of Psoriasis
Psoriasis is a chronic skin disease that affects approximately 2--3% of individuals in the Western world. New data have indicated that a subset of immune cells known as Tregs (which act to prevent other immune cells from responding inappropriately) are dysfunctional in a mouse model of psoriasis and that this dysfunction contributes substantially to the development of disease.
Psoriasis drugs put to the test
Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating patients with the condition.
Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
Conditions: Cardiovascular Diseases; Carotid Artery Diseases; Intracranial Arteriosclerosis; Cerebrovascular Disorders; Heart Diseases; Vascular Diseases; Atherosclerosis
Interventions: Drug: Vitamin E; Drug: Vitamin C
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Terminated - verified October 2006
Compromised Skin Barrier Function Plays A Role In Psoriasis Development
New research on genetic basis of psoriasis may prove important for early diagnosis and prediction of an individual's risk for this common chronic skin disease.
Pinning Down A Cause Of Disease In A Model Of Psoriasis
Psoriasis is a chronic skin disease that affects approximately 2--3% of individuals in the Western world. New data have indicated that a subset of immune cells known as Tregs (which act to prevent other immune cells from responding inappropriately) are dysfunctional in a mouse model of psoriasis and that this dysfunction contributes substantially to the development of disease.
Psoriasis drugs put to the test
Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating patients with the condition.
Conditions: Cardiovascular Diseases; Carotid Artery Diseases; Intracranial Arteriosclerosis; Cerebrovascular Disorders; Heart Diseases; Vascular Diseases; Atherosclerosis
Interventions: Drug: Vitamin E; Drug: Vitamin C
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Terminated - verified October 2006
Compromised Skin Barrier Function Plays A Role In Psoriasis Development
New research on genetic basis of psoriasis may prove important for early diagnosis and prediction of an individual's risk for this common chronic skin disease.
Pinning Down A Cause Of Disease In A Model Of Psoriasis
Psoriasis is a chronic skin disease that affects approximately 2--3% of individuals in the Western world. New data have indicated that a subset of immune cells known as Tregs (which act to prevent other immune cells from responding inappropriately) are dysfunctional in a mouse model of psoriasis and that this dysfunction contributes substantially to the development of disease.
Psoriasis drugs put to the test
Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating patients with the condition.
Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
Conditions: Cardiovascular Diseases; Carotid Artery Diseases; Intracranial Arteriosclerosis; Cerebrovascular Disorders; Heart Diseases; Vascular Diseases; Atherosclerosis
Interventions: Drug: Vitamin E; Drug: Vitamin C
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Terminated - verified October 2006
Compromised Skin Barrier Function Plays A Role In Psoriasis Development
New research on genetic basis of psoriasis may prove important for early diagnosis and prediction of an individual's risk for this common chronic skin disease.
Pinning Down A Cause Of Disease In A Model Of Psoriasis
Psoriasis is a chronic skin disease that affects approximately 2--3% of individuals in the Western world. New data have indicated that a subset of immune cells known as Tregs (which act to prevent other immune cells from responding inappropriately) are dysfunctional in a mouse model of psoriasis and that this dysfunction contributes substantially to the development of disease.
Psoriasis drugs put to the test
Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating patients with the condition.
